California Public Employees Retirement System Larimar Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 13, 2021	SELL	$8.0 - $15.2 $155,608 - $295,655	-19,451 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$14.28 - $25.06 $277,760 - $487,442	19,451 New	19,451 $416,000

Others Institutions Holding LRMR

# of Institutions

127

Shares Held

67.3M

Call Options Held

280K

Put Options Held

76.3K

Deerfield Management Company, L.P. (Series C) New York, NY

21.2M
Shares

$77.9 Million
2.59% of portfolio
Ra Capital Management, L.P. Boston, MA

6.05M
Shares

$22.2 Million
0.55% of portfolio
Janus Henderson Group PLC London, X0

5.57M
Shares

$20.4 Million
0.02% of portfolio
Goldman Sachs Group Inc New York, NY

4.25M
Shares

$15.6 Million
0.0% of portfolio
Blue Owl Capital Holdings LP New York, NY

4.17M
Shares

$15.3 Million
9.0% of portfolio

View Full List

About Larimar Therapeutics, Inc.

Ticker LRMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,269,200
Market Cap $159M
Description
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...

More about LRMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account